BBRRF

Blueberries Medical Corp.
OTC Markets OTCIDUSDEQUITY DELAYED
Last price
0.01
▲ 0.00 (16.98%)
MARKET ·

Price

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
Prev close
0.01
Day high
0.01
Day low
0.01
Volume
20.00K
Market cap
P/E (TTM)
52W range
0.00 – 0.02

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-4.86% -3.5%
1M
+11.00% +7.3%
3M
+7.42% +4.3%
6M
+25.66% +14.6%
YTD
+15.83% +3.5%
1Y
+0.15% -19.8%
3Y
-10.00% -84.2%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Free account

3 more panels on BBRRF open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap
Enterprise value
Revenue (TTM)
Gross profit
EBITDA
Net income
EPS (TTM)
Free cash flow
Total cash
Total debt
Book value / share
Shares outstanding
Float
Short % of float
Dividend yield
Beta (5Y)

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E
PEG ratio
Price / sales
Price / book
EV / revenue
EV / EBITDA
Gross margin
Operating margin
Profit margin
Return on equity
Return on assets
Debt / equity
Current ratio
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 5 years · 6 quarters
Blank means not reported, not zero
Line item20252024202320222021YoY
Total revenue $312.29K$471.41K$288.27K$235.45K -33.8%
Operating revenue $312.29K$471.41K$288.27K$235.45K -33.8%
Cost of revenue $164.46K$306.90K$204.05K$253.17K -46.4%
Gross profit $147.82K$164.52K$84.22K-$17.72K -10.1%
Selling, general & admin $1.31M$903.78K$1.22M$1.23M +44.5%
Total operating expense $1.53M$1.08M$1.46M$1.62M +41.7%
Operating income -$1.38M-$913.12K-$1.38M-$1.64M -51.0%
Net interest income $0-$263.84K-$360.08K-$269.42K
Pre-tax income -$1.67M-$1.15M-$1.64M-$1.47M -45.0%
Net income -$1.67M-$1.15M-$1.64M-$1.47M -45.0%
Net income to common -$1.67M-$1.15M-$1.64M-$1.47M -45.0%
Basic EPS 0.000.00-0.01-0.01
Diluted EPS 0.000.00-0.01-0.01
EBIT -$1.38M-$913.12K-$1.37M-$1.11M -51.0%
EBITDA -$1.28M-$807.92K-$1.22M-$811.47K -58.5%
Basic shares 472.98M399.03M219.30M168.89M +18.5%
Diluted shares 472.98M399.03M219.30M168.89M +18.5%

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
Consensus
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders
Held by institutions
Institutions holding
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
0.01
+4.03% from price
SMA 20
0.01
+17.01% from price
SMA 50
0.01
+17.40% from price
SMA 100
0.01
+11.53% from price
SMA 200
0.01
+19.96% from price
EMA 12
0.01
+3.53% from price
EMA 26
0.01
+5.82% from price
EMA 50
0.01
+7.59% from price
RSI (14)
54.1
Neutral
MACD (12,26,9)
0.00
Hist 0.00
ATR (14)
0.00
15.42% of price
Realised vol 30D
282.2%
Annualised
Bollinger upper
0.01
20, 2σ
Bollinger lower
0.01
20, 2σ
50 / 200 cross
Golden
0.01 vs 0.01
Trend bias
Above 200
+19.96%

Options chain

Account required
ExpirySpot 0.01
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.73
Less volatile than market
Correlation to SPY
-0.04
Largely independent
Realised vol 30D
282.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-63.2%
Peak to trough
Max drawdown 5Y
-93.8%
Peak to trough
ATR 14
0.00
15.42% of price
Beta (reported)
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.